These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
257 related items for PubMed ID: 6387638
21. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema. Abboud RT, Vimalanathan S. Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259 [Abstract] [Full Text] [Related]
22. The pathogenesis of pulmonary emphysema. Lancet; 1980 Apr 05; 1(8171):743-5. PubMed ID: 6103161 [No Abstract] [Full Text] [Related]
23. The elastase/alpha 1-proteinase inhibitor balance in the lung. A review. Virca GD, Schnebli HP. Schweiz Med Wochenschr; 1984 Jun 23; 114(25):895-8. PubMed ID: 6379867 [Abstract] [Full Text] [Related]
24. Pathogenesis and therapy of pulmonary emphysema. Rohatgi PK, Kuzmowych TV. Md Med J; 1993 Jul 23; 42(7):651-61. PubMed ID: 8412525 [Abstract] [Full Text] [Related]
26. [Genetic and acquired alpha 1-antitrypsin deficiency and development of pulmonary emphysema]. Pedersen CF. Ugeskr Laeger; 1984 Sep 10; 146(37):2770-2. PubMed ID: 6334920 [No Abstract] [Full Text] [Related]
27. [Prolastin in the treatment of mild emphysema in patients with alpha 1-protease inhibitor deficiency]. Ulrik CS, Dirksen A, Kok-Jensen A. Ugeskr Laeger; 1992 Mar 16; 154(12):811-2. PubMed ID: 1553776 [No Abstract] [Full Text] [Related]
39. [New theories on the role of genetically determined alpha 1-antitrypsindeficiency in the development of pulmonary emphysema]. Piłacik B, Hanke W. Pol Tyg Lek; 2006 Feb 28; 45(38-39):798-800. PubMed ID: 2095551 [No Abstract] [Full Text] [Related]